Growth Metrics

Summit Therapeutics (SMMT) Change in Cash (2019 - 2025)

Summit Therapeutics' Change in Cash history spans 7 years, with the latest figure at -$13.3 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 219.88% year-over-year to -$13.3 million; the TTM value through Dec 2025 reached $120.4 million, up 256.6%, while the annual FY2025 figure was $120.4 million, 256.6% up from the prior year.
  • Change in Cash reached -$13.3 million in Q4 2025 per SMMT's latest filing, up from -$59.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $526.6 million in Q4 2022 to a low of -$577.6 million in Q1 2023.
  • Average Change in Cash over 5 years is $8.0 million, with a median of -$3.6 million recorded in 2021.
  • Peak YoY movement for Change in Cash: surged 6327.22% in 2022, then crashed 10307.42% in 2023.
  • A 5-year view of Change in Cash shows it stood at -$8.5 million in 2021, then soared by 6327.22% to $526.6 million in 2022, then plummeted by 90.96% to $47.6 million in 2023, then crashed by 76.72% to $11.1 million in 2024, then crashed by 219.88% to -$13.3 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Change in Cash are -$13.3 million (Q4 2025), -$59.3 million (Q3 2025), and $86.3 million (Q2 2025).